المؤلفون: Nardinelli L; Tumor Biology Laboratory, Faculty of Medicine, University of São Paulo, Brazil., Sanabani SS, Didone A, Ferreira Pde B, Serpa M, Novaes MM, Marchiani M, Ruiz AL, Lima IS, Chamone Dde A, Bendit I

المصدر: Acta haematologica [Acta Haematol] 2012; Vol. 127 (4), pp. 228-34. Date of Electronic Publication: 2012 Apr 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Leukemia, Myeloid, Chronic-Phase/*drug therapy , Leukemia, Myeloid, Chronic-Phase/*genetics , Organic Cation Transporter 1/*genetics , Piperazines/*therapeutic use , Pyrimidines/*therapeutic use, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Benzamides ; Biomarkers, Tumor/genetics ; Disease-Free Survival ; Female ; Gene Expression ; Humans ; Imatinib Mesylate ; Kaplan-Meier Estimate ; Male ; Middle Aged ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA, Neoplasm/genetics ; RNA, Neoplasm/metabolism ; Real-Time Polymerase Chain Reaction ; Remission Induction ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Young Adult

المؤلفون: Bendit I; Tumor Biology Laboratory, University of São Paulo, São Paulo, Brazil. isbendit@usp.br, Sanabani SS, Conchon M, Serpa M, Novaes MM, Nardinelli L, Pereira TD, Tucunduva L, Ferreira Pde B, Dorlhiac-Llacer PE, Fischer Chamone Dde A

المصدر: Acta haematologica [Acta Haematol] 2012; Vol. 128 (4), pp. 223-32. Date of Electronic Publication: 2012 Aug 22.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Leukemia, Myeloid, Chronic-Phase/*drug therapy , Piperazines/*therapeutic use , Pyrimidines/*therapeutic use, Adolescent ; Aged ; Aged, 80 and over ; Benzamides ; Female ; Humans ; Imatinib Mesylate ; Interferon-alpha/therapeutic use ; Leukemia, Myeloid, Chronic-Phase/mortality ; Male ; Middle Aged ; Prognosis ; Survival Rate ; Treatment Outcome

المؤلفون: Tanizawa RS; Cytogenetics Laboratory, Serviço de Hematologia do Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - USP, São Paulo, SP, Brazil., Kumeda CA, de Azevedo Neto RS, Leal Ade M, Ferreira Pde B, Velloso ED

المصدر: Revista brasileira de hematologia e hemoterapia [Rev Bras Hematol Hemoter] 2011; Vol. 33 (6), pp. 425-31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Brazil NLM ID: 101220159 Publication Model: Print Cited Medium: Internet ISSN: 1806-0870 (Electronic) Linking ISSN: 15168484 NLM ISO Abbreviation: Rev Bras Hematol Hemoter Subsets: PubMed not MEDLINE

المؤلفون: Serpa M; Department of Hematology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil. isbendit@usp.br., Sanabani SS, Dorliac-Llacer PE, Conchon M, Pereira TD, Nardinelli L, Costa JL, Novaes MM, Ferreira Pde B, Bendit I

المصدر: BMC blood disorders [BMC Blood Disord] 2010 Nov 18; Vol. 10, pp. 7. Date of Electronic Publication: 2010 Nov 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968550 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2326 (Electronic) Linking ISSN: 14712326 NLM ISO Abbreviation: BMC Blood Disord Subsets: PubMed not MEDLINE